Skip to main content

The Institut Bordet Clinical Haematology Department specialises in determining and treating diseases of the blood.

The Institut Bordet is committed to the treatment of these diseases and to offering patients high-quality, individual treatment.

In addition to the traditional approach to blood diseases, the Institut is also engaged in the development of innovative and complex techniques and therapies.

The Institut’s mission covers three main university fields: clinical, research and teaching.

The multidisciplinary nature of the Department, in both its diagnostic and therapeutic approaches, forms an integral part of all decisions concerning the patient.

Research projects

Participation of the Hematology Department in research projects with the following laboratories :

EXPERIMENTAL HAEMATOLOGY LABORATORY (HEMEXP)
CLINICAL CELLULAR THERAPY RESEARCH LABORATORY (LTCC)

 

Project 1

The prognostic value of cognitive function, biomarkers of ageing and clinical factors in elderly patients with malignant haemopathy admitted for chemotherapy (Dominique Bron, MD, PhD)
  • Project leader : Stéphanie Dubruille
  • Collaborations : H. Wildiers, M. Delforge (KUL)
  • Funding : Télévie, FNRS

Project 2

Interculturality and Transplantation  

Project 3

Role of radio-immunotherapy in myeloma

Project 4

Protocoles de recherche clinique académiques et pharmaceutiques
  • Project leaders : Dominique Bron and colleagues
  • Funding : Fonds Ariane, Pharma

Our team

Head of Department
Prof Dominique BronHaematological Medicine (lymphoma and chronic lymphoid leukaemia)

Heads of Clinic
- Prof Nathalie Meuleman - Haematological Medicine (Multiple myeloma and plasmocytary disorders)
- Prof Philippe Lewalle - Haematological Medicine (myeloproliferative syndrome, chronic myeloid leukaemia and transplantations)
- Prof Marie Maerevoet - Haematological Medicine (lymphomas and lymphoproliferative disorders, new drugs)
- Prof Sebastian Wittnebel - Haematological Medicine (leukaemia, myelodysplasia and transplantations)
- Dr Cécile Springael
Haematological Medicine (T lymphomas and rare lymphomas)

Resident
- Dr Marie Vercruyssen - Haematological Medicine

Hospital Assistant
- Dr Chloé Spilleboudt - Haematological Medicine

Head Nursing (Tel : +32 (0)2 541 33 55)
Patrick Crombez

Nursing « health education » (Tel : +32 (0)2 541 33 30)
- Marie-France Jaivenois

Nurses (health care coordinators) (Tel : +32 (0)2 541 73 94)
- Sophie Delaunois
- Zilfi Balci

Cytapheresis unit and Stem Cell Collection (Tel : +32 (0)2 541 32 11)
Philippe Lewalle – Responsible physician
Phuong Huynh – General practitioner
- Corine Mal – Nurse
- Walter Bellemans – Nurse
- Munteanu Nicoleta – Nurse

Transplantation Coordinator (Tel : +32 (0)2 541 32 12)
- Sandra Michiels – Coordinator

Data Managing Unit
- Anne De Meuter – Head Nurse (Tel : +32 (0)2 541 72 05)
- Dominique De Poorter – Nurse (Tel : +32 (0)2 541 35 98)
- Sabrina Costantini – administrative (Tel : +32 (0)2 541 37 55)
- Sabrina Amaouche – Nurse (Tel : +32 (0)2 541 36 47)
- Delphine Leva – administrative (Tel : +32 (0)2 541 33 57)

Quality Cell
- Phuong Huynh – Physician
- Olivier Urbain – Pharmacist qualitician

Secretariat 
- Sabine Ackermans (administration) - Tel : +32 (0)2 541 37 28
- Jennifer Marinus (consultation) - Tel : +32 (0)2 541 36 84

 Scientific publications

Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic.

Authors : Najar M, Krayem M, Meuleman N, Bron D, Hélène B, Lagneaux L
Year : 2018
Journal : Appl Immunohistochem Mol Morphol
Volume : 26(3)
Pages : e26-e43

Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.

Authors : Najar M, Krayem M, Merimi M, Burny A, Meuleman N, Bron D, Raicevic G, Lagneaux L
Year : 2018
Journal : Inflamm Res
Volume : 67(6)
Pages : 467-477

Mesenchymal stromal cells of the bone marrow and natural killer cells: cell interactions and cross modulation.

Authors : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2018
Journal : J Cell Commun Signal

Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture.

Authors : Najar M, Fayyad-Kazan M, Meuleman N, Bron D, Fayyad-Kazan H, Lagneaux L
Year : 2018
Journal : Mol Cell Biochem

Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data.

Authors : Zardavas D, Te Marvelde L, Milne RL, Fumagalli D, Fountzilas G, Kotoula V, Razis E, Papaxoinis G, Joensuu H, Moynahan ME, Hennessy BT, Bieche I, Saal LH, Stal O, Iacopetta B, Jensen JD, OToole S, Lopez-Knowles E, Barbaraeschi M, Noguchi S, Azim HA Jr, Lerma E, Bachelot T, Wang Q, Perez-Tenorio G, Can de Velde CJH, Rea DW, Sabine V, Bartlett JMS, Sotiriou C, Michiels S, Loi S
Year : 2018
Journal : J Clin Oncol
Volume : 36(10)
Pages : 981-990

Support research

Support research

Research at the Institut Jules Bordet depends on your generosity. Make a donation today and join us in the fight against cancer.

Learn more